Skip to content
10-K

Annual Report

eFFECTOR Therapeutics, Inc.

0000950170-24-036169

← back to feed
Filed
Mar 26, 2024 12:00 AM ET
Period of report
—
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Feb 29, 2024 3.69M sh
Shares Diluted FY 2023 · Dec 31, 2023 2.19M sh
Shares Diluted restated FY 2023 · Dec 31, 2022 1.65M sh
Capex FY 2023 · Dec 31, 2023 $97K
Capex FY 2023 · Dec 31, 2022 $192K
Operating Cash Flow FY 2023 · Dec 31, 2023 −$29.55M
Operating Cash Flow FY 2023 · Dec 31, 2022 −$25.9M
Short Term Investments FY 2023 · Dec 31, 2023 $3.5M
Short Term Investments FY 2023 · Dec 31, 2022 $17.6M
Cash And Equivalents FY 2023 · Dec 31, 2023 $14.88M
Cash And Equivalents FY 2023 · Dec 31, 2022 $8.71M
Stockholders Equity FY 2023 · Dec 31, 2023 −$5.8M
Stockholders Equity FY 2023 · Dec 31, 2022 $3.9M
Stockholders Equity FY 2023 · Dec 31, 2021 $17.28M
Current Liabilities FY 2023 · Dec 31, 2023 $25.8M
Current Liabilities FY 2023 · Dec 31, 2022 $25.08M
Total Liabilities FY 2023 · Dec 31, 2023 $26.34M
Total Liabilities FY 2023 · Dec 31, 2022 $25.18M
Current Assets FY 2023 · Dec 31, 2023 $19.84M
Current Assets FY 2023 · Dec 31, 2022 $28.01M
Total Assets FY 2023 · Dec 31, 2023 $20.54M
Total Assets FY 2023 · Dec 31, 2022 $29.08M
Eps Diluted FY 2023 · Dec 31, 2023 −$16.37
Eps Diluted restated FY 2023 · Dec 31, 2022 −$13.76
Eps Basic FY 2023 · Dec 31, 2023 −$16.37
Eps Basic restated FY 2023 · Dec 31, 2022 −$13.76
Sga Expense FY 2023 · Dec 31, 2023 $10.93M
Sga Expense FY 2023 · Dec 31, 2022 $12.64M
Rd Expense FY 2023 · Dec 31, 2023 $22.92M
Rd Expense FY 2023 · Dec 31, 2022 $23.31M
Net Income FY 2023 · Dec 31, 2023 −$35.81M
Net Income FY 2023 · Dec 31, 2022 −$22.67M
Operating Income FY 2023 · Dec 31, 2023 −$33.84M
Operating Income FY 2023 · Dec 31, 2022 −$32.4M
Revenue FY 2023 · Dec 31, 2023 $0
Revenue FY 2023 · Dec 31, 2022 $3.55M